Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P0518: Study of the prevalence of defecatory disorders in patients with quiescent ulcerative colitis using high resolution anorectal manometryECCO'25
Year: 2025
Authors: Abdelaty, K.(1)*;
(1)Alexandria Unversiaty, Internal medicine-gastroenterology unit, Alex, Egypt; Hussein Saad Eman Abu El-Soud Ezzat Ali

Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019; 65:100-51.
Kang HR, Lee JE, Lee JS, Lee TH, Hong SJ, Kim JO, et al. Comparison of high-resolution anorectal manometry with water-perfused anorectal manometry. J Neurogastroenterol Motil. 2015; 21:126-32.
Torresan F, Mandolesi D, Bonventre S, Usai P. Differences between conventional anorectal manometry and high resolution\high-definition anorectal manometry. In: Bellini M, editor. High resolution and high-definition anorectal manometry. 5. Cham: Springer; 2020. p.49-68.

P0519: Upadacitinib in Acute Severe Ulcerative Colitis among previously anti-TNFa exposed patients.ECCO'25
Year: 2025
Authors: Manti, M.(1)*;Kamperidis, N.(1);Toskas, A.(1);Misra, R.(1);Arebi, N.(1);
(1)St Mark's Hospital, Gastroenterology, London, United Kingdom;

1.Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019;114(3):384-413. doi:10.14309/ajg.0000000000000152
2.Berinstein JA, Karl T, Patel A, et al. Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience. Am J Gastroenterol. 2024;119(7):1421-1425. doi:10.14309/ajg.0000000000002674
3.Ali NM, Shehab MA. Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature. Am J Case Rep. 2023;24. doi:10.12659/AJCR.940966

P0520: Association between interoception and Visceral Hypervigilance in patients with Inflammatory Bowel DiseaseECCO'25
Year: 2025
Authors: Knödler, L.L.(1)*;Rösch, T.(1);Atanasova, K.(1);Ebert, M.(1);Thomann, A.(1);Reindl, W.(1);
(1)Medical Faculty Mannheim - Heidelberg University, Department of Medicine II, Mannheim, Germany;

1          Thomann AK, Knödler LL, Karthikeyan S, et al. The Interplay of Biopsychosocial Factors and Quality of Life in Inflammatory Bowel Diseases: A Network Analysis. J Clin Gastroenterol. 2023;57(1):57-65. Published 2023 Jan 1. doi:10.1097/MCG.0000000000001625

2          Herbert BM, Muth ER, Pollatos O, Herbert C. Interoception across modalities: on the relationship between cardiac awareness and the sensitivity for gastric functions. PLoS One. 2012;7(5):e36646. doi:10.1371/journal.pone.0036646

3          Whitehead WE, Drescher VM. Perception of gastric contractions and self-control of gastric motility. Psychophysiology. 1980;17(6):552-558. doi:10.1111/j.1469-8986.1980.tb02296.x

P0521: Accuracy of a non-invasive approach in monitoring pediatric inflammatory bowel disease: interim-analysis of a prospective multicenter italian studyECCO'25
Year: 2025
Authors: D'Arcangelo, G.(1)*;Gravina, A.(1);Colucci, A.(2);Raso, T.(1);Casertano, M.(2);Cenni, S.(2);Strisciuglio, C.(2);Maccioni, F.(3);Oliva, S.(1);
(1)Sapienza University of Rome, Maternal and Child Health Department, Rome, Italy;(2)University of Campania "Luigi Vanvitelli", Department of Woman- Child and General and Specialistic Surgery, Naples, Italy;(3)Sapienza University of Rome, Department of Radiological- Oncology and Patological Sciences, Rome, Italy;
P0522: Transmural healing rate does not differ between Crohn's disease patients with structural damage versus inflammatory behaviorECCO'25
Year: 2025
Authors: Marques Garcia, P.(1)*;Albert Palomares , S.(1);Fquihi Chetouani, M.(1);Torrente Sánchez, J.(1); Pérez Ibáñez, A.A.(1);Rabadán Mata, A.(1);Peiró García, E.(1);Blanc Garcia, E.(2);Martinez Perez, M.J.(2);Paredes Arquiola, J.M.(1);
(1)Hospital Doctor Peset, Department of Digestive Medicine, Valencia, Spain;(2)Hospital Doctor Peset, Department of Diagnostic Radiology, Valencia, Spain; Transmural healing rate does not differ between crohn's disease patients with structural damage versus inflammatory behavior

1.Wilkens R, Novak KL, Maaser C, et al. Relevance of monitoring transmural disease activity in patients with Crohn's disease: current status and future perspectives. TherapAdvGastroenterol. 2021. doi: 10.1177/17562848211006672.
2.Paredes JM, Moreno N, Latorre P, et al. Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease. Dig Dis Sci. 2019;64:2600-2606. 
3.Muñoz F, Ripollés T, Poza Cordón J, et al. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. GastroenterolHepatol. 2021;44:158-174. 
4.Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography Tight Control and Monitoring in Crohn's Disease During Different Biological Therapies: A Multicenter Study. ClinGastroenterolHepatol. 2022;20:711-722. 
5.Fraquelli M, Castiglione F, Calabrese E, et al. Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice. Dig Liver Dis. 2020;52:9-18.
6.Fiorino G, Bonifacio C, Allocca M, et al. Impact of therapies on bowel damage in Crohn's disease. United European Gastroenterol J. 2020;8:410-417.

P0523: Comparative analysis of two ELISA methods for measuring serum ustekinumab levels in Inflammatory Bowel Disease ¿Is interchangeability feasible?